Coexpression cluster:C320

Full id: C320_Olfactory_Ewing_smooth_hepatic_Hair_Mesenchymal_Preadipocyte

Phase1 CAGE Peaks

Hg19::chr7:134528663..134528702,+	p22@CALD1
Hg19::chr7:134552465..134552517,+	p1@CU691860
Hg19::chr7:134613495..134613506,+	p45@CALD1
Hg19::chr7:134613535..134613560,+	p29@CALD1
Hg19::chr7:134613586..134613622,+	p13@CALD1
Hg19::chr7:134617744..134617765,+	p18@CALD1
Hg19::chr7:134617784..134617809,+	p10@CALD1
Hg19::chr7:134617787..134617804,-	p@chr7:134617787..134617804 -
Hg19::chr7:134617811..134617848,+	p8@CALD1
Hg19::chr7:134617854..134617915,+	p4@CALD1
Hg19::chr7:134617917..134617937,+	p17@CALD1
Hg19::chr7:134617937..134617982,-	p@chr7:134617937..134617982 -
Hg19::chr7:134617940..134617951,+	p32@CALD1
Hg19::chr7:134617957..134617991,+	p11@CALD1
Hg19::chr7:134617984..134617989,-	p@chr7:134617984..134617989 -
Hg19::chr7:134617990..134618123,-	p@chr7:134617990..134618123 -
Hg19::chr7:134617994..134618020,+	p20@CALD1
Hg19::chr7:134618090..134618112,+	p16@CALD1
Hg19::chr7:134618124..134618144,-	p@chr7:134618124..134618144 -
Hg19::chr7:134625860..134625881,+	p38@CALD1
Hg19::chr7:134625866..134625911,-	p@chr7:134625866..134625911 -
Hg19::chr7:134625911..134625928,+	p34@CALD1
Hg19::chr7:134625914..134625938,-	p@chr7:134625914..134625938 -
Hg19::chr7:134632290..134632346,+	p@chr7:134632290..134632346 +
Hg19::chr7:134632354..134632417,+	p@chr7:134632354..134632417 +
Hg19::chr7:134632438..134632530,-	p@chr7:134632438..134632530 -
Hg19::chr7:134635150..134635191,-	p@chr7:134635150..134635191 -
Hg19::chr7:134644722..134644760,+	p44@CALD1
Hg19::chr7:134653144..134653160,+	p@chr7:134653144..134653160 +
Hg19::chr7:134653476..134653488,+	p@chr7:134653476..134653488 +
Hg19::chr7:134653623..134653707,+	p@chr7:134653623..134653707 +
Hg19::chr7:134653818..134653846,+	p26@CALD1
Hg19::chr7:134653919..134653969,+	p30@CALD1
Hg19::chr7:134654032..134654049,+	p39@CALD1
Hg19::chr7:134654089..134654182,+	p23@CALD1
Hg19::chr7:134654295..134654363,+	p21@CALD1
Hg19::chr7:134654434..134654479,+	p36@CALD1

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0017022	myosin binding	0.0049452490286118
GO:0005523	tropomyosin binding	0.00649063935005298
GO:0005516	calmodulin binding	0.0203991522430237
GO:0006936	muscle contraction	0.0203991522430237
GO:0003012	muscle system process	0.0203991522430237
GO:0051674	localization of cell	0.0338219710349699
GO:0006928	cell motility	0.0338219710349699
GO:0003779	actin binding	0.033844048039562
GO:0008092	cytoskeletal protein binding	0.0414164606146238

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

---

Cell Type

Ontology term	p-value	n
non-terminally differentiated cell	8.25e-23	180
fibroblast	1.71e-13	75
embryonic cell	1.67e-08	248
muscle precursor cell	1.37e-07	57
myoblast	1.37e-07	57
multi-potent skeletal muscle stem cell	1.37e-07	57
electrically responsive cell	2.46e-07	60
electrically active cell	2.46e-07	60
muscle cell	3.60e-07	54
skin fibroblast	5.78e-07	23
preadipocyte	7.74e-07	12

Uber Anatomy

Ontology term	p-value	n
multi-cellular organism	4.13e-17	659
organism subdivision	7.40e-16	365
multi-tissue structure	7.18e-14	347
anatomical system	1.49e-12	625
anatomical group	2.53e-12	626
trunk mesenchyme	5.89e-11	143
surface structure	2.83e-10	95
anatomical cluster	4.54e-10	286
somite	5.69e-10	83
paraxial mesoderm	5.69e-10	83
presomitic mesoderm	5.69e-10	83
presumptive segmental plate	5.69e-10	83
trunk paraxial mesoderm	5.69e-10	83
presumptive paraxial mesoderm	5.69e-10	83
embryo	1.95e-09	612
trunk	2.85e-09	216
embryonic structure	6.90e-09	605
developing anatomical structure	6.90e-09	605
germ layer	1.30e-08	604
embryonic tissue	1.30e-08	604
presumptive structure	1.30e-08	604
epiblast (generic)	1.30e-08	604
epithelium	1.32e-08	309
cell layer	1.72e-08	312
muscle tissue	2.15e-08	63
musculature	2.15e-08	63
musculature of body	2.15e-08	63
mesenchyme	2.64e-08	238
entire embryonic mesenchyme	2.64e-08	238
multilaminar epithelium	4.47e-08	82
dermomyotome	6.44e-08	70
skeletal muscle tissue	9.30e-08	61
striated muscle tissue	9.30e-08	61
myotome	9.30e-08	61
reproductive structure	2.12e-07	59
reproductive system	2.12e-07	59
organ	5.42e-07	511
anatomical conduit	6.37e-07	241
unilaminar epithelium	8.38e-07	138
integument	9.49e-07	45
integumental system	9.49e-07	45

Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}

ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data

---

No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data

---

This analysis result is provided for C0 - C305 clusters.